Ikarian Capital
Latest statistics and disclosures from Ikarian Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CDTX, XBI, AMGN, TERN, ABVX, and represent 32.91% of Ikarian Capital's stock portfolio.
- Added to shares of these 10 stocks: AMGN (+$80M), CDTX (+$65M), TERN (+$58M), OMER (+$26M), OLMA (+$24M), CORT (+$20M), HROW (+$20M), Jazz Pharmaceuticals Plc cmn (+$17M), NBIX (+$15M), LLY (+$15M).
- Started 47 new stock positions in GOSS, CELC, LLY, PHGE, MLYS, JBIO, VSTM, SHPH, ALMS, IVA.
- Reduced shares in these 10 stocks: , GMAB (-$53M), BMY (-$36M), INSM (-$34M), PTCT (-$29M), SRRK (-$25M), TVTX (-$14M), DNTH (-$14M), PRAX (-$12M), Biohaven (-$12M).
- Sold out of its positions in Aethlon Med, AKRO, ALT, ANAB, ARCT, ARGX, Biomx, BBIO, BMY, TVRD.
- Ikarian Capital was a net buyer of stock by $83M.
- Ikarian Capital has $1.3B in assets under management (AUM), dropping by 29.41%.
- Central Index Key (CIK): 0001778253
Tip: Access up to 7 years of quarterly data
Positions held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Ikarian Capital
Ikarian Capital holds 148 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Cidara Therapeutics Com New (CDTX) | 9.9 | $127M | +106% | 573k | 220.89 |
|
| Spdr Series Trust State Street Spd Put Option (XBI) | 8.1 | $104M | +13% | 850k | 121.93 |
|
| Amgen (AMGN) | 6.3 | $80M | NEW | 245k | 327.31 |
|
| Terns Pharmaceuticals (TERN) | 5.0 | $65M | +872% | 1.6M | 40.40 |
|
| Abivax Sa Sponsored Ads (ABVX) | 3.7 | $47M | -16% | 331k | 141.42 |
|
| Harrow Health (HROW) | 2.6 | $34M | +139% | 693k | 49.00 |
|
| Rapt Therapeutics Com New (RAPT) | 2.5 | $32M | +20% | 955k | 33.87 |
|
| Cytokinetics Com New (CYTK) | 2.3 | $30M | +38% | 464k | 63.54 |
|
| Jazz Pharmaceuticals Call Call Option | 2.3 | $29M | +140% | 170k | 170.00 |
|
| Soleno Therapeutics (SLNO) | 2.2 | $28M | +111% | 598k | 46.30 |
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.1 | $27M | +106% | 160k | 170.00 |
|
| Maze Therapeatics (MAZE) | 2.1 | $27M | -12% | 645k | 41.43 |
|
| Omeros Corporation Call Option (OMER) | 2.0 | $26M | NEW | 1.5M | 17.18 |
|
| Praxis Precision Medicines I Com New (PRAX) | 2.0 | $26M | -32% | 87k | 294.74 |
|
| Olema Pharmaceuticals (OLMA) | 1.9 | $24M | NEW | 959k | 25.00 |
|
| Ionis Pharmaceuticals (IONS) | 1.8 | $24M | -30% | 297k | 79.11 |
|
| Corcept Therapeutics Incorporated (CORT) | 1.6 | $20M | NEW | 586k | 34.80 |
|
| Kodiak Sciences (KOD) | 1.6 | $20M | +73% | 720k | 27.96 |
|
| Revolution Medicines (RVMD) | 1.4 | $19M | +145% | 233k | 79.65 |
|
| Vaxcyte (PCVX) | 1.4 | $18M | +18% | 379k | 46.14 |
|
| Crinetics Pharmaceuticals In Put Option (CRNX) | 1.3 | $17M | -5% | 369k | 46.55 |
|
| Capricor Therapeutics Com New (CAPR) | 1.3 | $17M | +24% | 578k | 28.86 |
|
| Fulcrum Therapeutics (FULC) | 1.2 | $16M | +6% | 1.4M | 11.31 |
|
| Neurocrine Biosciences (NBIX) | 1.2 | $15M | NEW | 105k | 141.83 |
|
| Eli Lilly & Co. (LLY) | 1.2 | $15M | NEW | 14k | 1074.68 |
|
| Relmada Therapeutics (RLMD) | 1.2 | $15M | +66% | 3.1M | 4.83 |
|
| Connect Biopharma Hldgs SHS (CNTB) | 1.1 | $14M | NEW | 4.9M | 2.82 |
|
| Cytomx Therapeutics (CTMX) | 1.1 | $14M | -5% | 3.2M | 4.26 |
|
| Pharvaris N V (PHVS) | 1.1 | $14M | +131% | 487k | 27.75 |
|
| Bright Minds Biosciences Com New (DRUG) | 1.0 | $12M | +933% | 159k | 78.04 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.9 | $12M | +459% | 518k | 23.00 |
|
| Tenax Therapeutics Com New (TENX) | 0.9 | $12M | 968k | 12.19 |
|
|
| Spruce Biosciences Com New (SPRB) | 0.8 | $11M | +810% | 121k | 87.11 |
|
| Celcuity (CELC) | 0.8 | $11M | NEW | 106k | 99.74 |
|
| Apellis Pharmaceuticals (APLS) | 0.8 | $10M | -50% | 397k | 25.12 |
|
| Alto Neuroscience Com Shs (ANRO) | 0.7 | $9.2M | +368% | 515k | 17.80 |
|
| Dex Call Option (DXCM) | 0.7 | $9.1M | NEW | 138k | 66.37 |
|
| Ptc Therapeutics I (PTCT) | 0.7 | $9.0M | -75% | 119k | 75.96 |
|
| Ventyx Biosciences (VTYX) | 0.7 | $8.7M | -26% | 959k | 9.03 |
|
| Cg Oncology (CGON) | 0.6 | $8.3M | -20% | 200k | 41.52 |
|
| Forte Biosciences Com New (FBRX) | 0.6 | $8.2M | 300k | 27.27 |
|
|
| Pelthos Therapeutics Com Shs (PTHS) | 0.6 | $7.9M | +309% | 256k | 31.00 |
|
| Mineralys Therapeutics (MLYS) | 0.6 | $7.3M | NEW | 200k | 36.29 |
|
| Agios Pharmaceuticals (AGIO) | 0.5 | $6.9M | -8% | 253k | 27.22 |
|
| Alpha Cognition Com New (ACOG) | 0.5 | $6.9M | +11% | 1.1M | 6.50 |
|
| Galecto Com New (GLTO) | 0.5 | $6.6M | NEW | 286k | 23.01 |
|
| Adagio Therapeutics (IVVD) | 0.5 | $6.6M | +27% | 2.7M | 2.47 |
|
| Biosante Pharmaceuticals Call Option (ANIP) | 0.5 | $6.5M | NEW | 83k | 78.94 |
|
| Nuvalent Inc-a (NUVL) | 0.5 | $6.0M | NEW | 60k | 100.59 |
|
| Lexeo Therapeutics (LXEO) | 0.4 | $5.1M | -9% | 513k | 9.93 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.4 | $4.9M | NEW | 227k | 21.74 |
|
| Pepgen (PEPG) | 0.4 | $4.9M | +39% | 747k | 6.51 |
|
| Jade Biosciences Com New (JBIO) | 0.4 | $4.6M | NEW | 300k | 15.43 |
|
| Eupraxia Pharmaceuticals (EPRX) | 0.4 | $4.6M | NEW | 610k | 7.55 |
|
| Delcath Sys Com New (DCTH) | 0.3 | $4.4M | 431k | 10.10 |
|
|
| Compass Therapeutics (CMPX) | 0.3 | $4.3M | NEW | 800k | 5.37 |
|
| Adma Biologics (ADMA) | 0.3 | $4.3M | +46% | 235k | 18.24 |
|
| Arvinas Ord (ARVN) | 0.3 | $4.2M | +58% | 358k | 11.86 |
|
| Zura Bio Class A Ord Shs (ZURA) | 0.3 | $4.2M | -62% | 802k | 5.24 |
|
| Karyopharm Therapeutics Com New (KPTI) | 0.3 | $4.0M | +1897% | 545k | 7.36 |
|
| Krystal Biotech (KRYS) | 0.3 | $3.7M | -39% | 15k | 246.54 |
|
| Tg Therapeutics (TGTX) | 0.3 | $3.5M | -32% | 118k | 29.81 |
|
| Vir Biotechnology (VIR) | 0.3 | $3.5M | -2% | 576k | 6.03 |
|
| Zenas Biopharma Call Option (ZBIO) | 0.3 | $3.4M | NEW | 94k | 36.31 |
|
| Nextcure Com New (NXTC) | 0.3 | $3.4M | NEW | 238k | 14.19 |
|
| Solid Biosciences Com New (SLDB) | 0.3 | $3.3M | -9% | 584k | 5.64 |
|
| Alector (ALEC) | 0.3 | $3.2M | +174% | 2.1M | 1.56 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.3 | $3.2M | NEW | 283k | 11.43 |
|
| Aquestive Therapeutics Put Option (AQST) | 0.3 | $3.2M | NEW | 500k | 6.46 |
|
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.2 | $3.1M | NEW | 241k | 13.03 |
|
| Insmed Com Par $.01 (INSM) | 0.2 | $3.1M | -91% | 18k | 174.04 |
|
| Gossamer Bio Call Option (GOSS) | 0.2 | $3.1M | NEW | 1.0M | 3.10 |
|
| Nektar Therapeutics Com New Call Option (NKTR) | 0.2 | $3.1M | NEW | 73k | 42.28 |
|
| Quoin Pharmaceuticals Sponsored Ads (QNRX) | 0.2 | $3.1M | NEW | 212k | 14.43 |
|
| Kalaris Therapeutics (KLRS) | 0.2 | $3.0M | NEW | 360k | 8.44 |
|
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.2 | $3.0M | +67% | 1.5M | 2.02 |
|
| Compass Pathways Sponsored Ads (CMPS) | 0.2 | $2.8M | 400k | 6.90 |
|
|
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.2 | $2.8M | -10% | 220k | 12.52 |
|
| Erasca (ERAS) | 0.2 | $2.7M | NEW | 735k | 3.72 |
|
| Tarsus Pharmaceuticals (TARS) | 0.2 | $2.6M | -57% | 31k | 81.88 |
|
| Uniqure Nv Call Call Option | 0.2 | $2.5M | -80% | 105k | 23.93 |
|
| Fractyl Health (GUTS) | 0.2 | $2.4M | -38% | 1.1M | 2.20 |
|
| Biohaven (BHVN) | 0.2 | $2.4M | NEW | 213k | 11.29 |
|
| Inventiva Sa Ads (IVA) | 0.2 | $2.3M | NEW | 503k | 4.63 |
|
| Neumora Therapeutics (NMRA) | 0.2 | $2.3M | +10128% | 1.3M | 1.79 |
|
| Cumberland Pharmaceuticals (CPIX) | 0.2 | $2.2M | 556k | 3.98 |
|
|
| Uniqure Nv SHS (QURE) | 0.2 | $2.2M | +55% | 91k | 23.93 |
|
| Dbv Technologies S A Sponsored Ads (DBVT) | 0.2 | $2.1M | NEW | 525k | 3.97 |
|
| Alumis Put Option (ALMS) | 0.2 | $2.1M | NEW | 211k | 9.76 |
|
| Cabaletta Bio (CABA) | 0.2 | $2.0M | NEW | 900k | 2.19 |
|
| Journey Med Corp (DERM) | 0.2 | $1.9M | NEW | 251k | 7.71 |
|
| Ibio Com New (IBIO) | 0.1 | $1.8M | +55% | 957k | 1.93 |
|
| Silence Therapeutics Ads (SLN) | 0.1 | $1.7M | -3% | 866k | 2.00 |
|
| Verastem Com New (VSTM) | 0.1 | $1.7M | NEW | 214k | 7.72 |
|
| Avalo Therapeutics Com New (AVTX) | 0.1 | $1.6M | -44% | 89k | 18.16 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.1 | $1.6M | -57% | 46k | 35.08 |
|
| Lipocine Com New (LPCN) | 0.1 | $1.6M | NEW | 200k | 8.03 |
|
| Surrozen Com New (SRZN) | 0.1 | $1.5M | NEW | 66k | 22.60 |
|
| Wave Life Sciences SHS (WVE) | 0.1 | $1.4M | -11% | 85k | 17.00 |
|
| Travere Therapeutics Call Option (TVTX) | 0.1 | $1.4M | -90% | 37k | 38.21 |
|
| Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $1.3M | -50% | 57k | 23.34 |
|
| Lyell Immunopharma Com New (LYEL) | 0.1 | $1.3M | -6% | 41k | 30.78 |
|
| Annexon (ANNX) | 0.1 | $1.2M | NEW | 230k | 5.02 |
|
| Cybin Com New (HELP) | 0.1 | $1.1M | -5% | 132k | 8.18 |
|
| Neuronetics (STIM) | 0.1 | $968k | -22% | 701k | 1.38 |
|
| Direxion Shs Etf Tr Daily S&p Biotec (LABD) | 0.1 | $860k | -55% | 41k | 21.06 |
|
| Io Biotech (IOBT) | 0.1 | $844k | -9% | 1.4M | 0.61 |
|
| Mind Medicine Mindmed Com New (MNMD) | 0.1 | $787k | -6% | 59k | 13.39 |
|
| Traws Pharma Com New (TRAW) | 0.1 | $766k | +2280% | 678k | 1.13 |
|
| Palisade Bio (PALI) | 0.1 | $646k | NEW | 275k | 2.35 |
|
| Kezar Life Sciences Com New (KZR) | 0.1 | $643k | -4% | 102k | 6.29 |
|
| Kalvista Pharmaceuticals (KALV) | 0.0 | $567k | -91% | 35k | 16.15 |
|
| Acumen Pharmaceuticals (ABOS) | 0.0 | $537k | -4% | 254k | 2.11 |
|
| Sangamo Biosciences (SGMO) | 0.0 | $512k | -5% | 1.2M | 0.42 |
|
| Immatics SHS (IMTX) | 0.0 | $510k | 49k | 10.50 |
|
|
| Equillium (EQ) | 0.0 | $471k | -8% | 304k | 1.55 |
|
| Ovid Therapeutics (OVID) | 0.0 | $404k | -77% | 248k | 1.63 |
|
| Immunic (IMUX) | 0.0 | $360k | -26% | 675k | 0.53 |
|
| Evaxion As Sponsored Ads (EVAX) | 0.0 | $356k | -6% | 75k | 4.77 |
|
| Vistagen Therapeutics Ord (VTGN) | 0.0 | $344k | -16% | 519k | 0.66 |
|
| Viking Therapeutics (VKTX) | 0.0 | $342k | -2% | 9.7k | 35.18 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $336k | -97% | 4.8k | 69.55 |
|
| Veru Com New (VERU) | 0.0 | $286k | -6% | 134k | 2.14 |
|
| CNS Pharmaceuticals (CNSP) | 0.0 | $241k | NEW | 46k | 5.25 |
|
| Sensei Biotherapeutics Com New (SNSE) | 0.0 | $228k | -5% | 21k | 10.67 |
|
| Nyxoah S A SHS (NYXH) | 0.0 | $218k | -6% | 47k | 4.60 |
|
| Voyager Therapeutics (VYGR) | 0.0 | $209k | -4% | 53k | 3.93 |
|
| Lexicon Pharmaceuticals Com New (LXRX) | 0.0 | $189k | -6% | 165k | 1.15 |
|
| Neuphoria Therapeutics (NEUP) | 0.0 | $184k | NEW | 47k | 3.88 |
|
| Glucotrack Com New (GCTK) | 0.0 | $177k | NEW | 46k | 3.87 |
|
| Vyne Therapeutics (VYNE) | 0.0 | $154k | -8% | 265k | 0.58 |
|
| Cartesian Therapeutics Com New (RNAC) | 0.0 | $150k | -6% | 21k | 7.21 |
|
| Shuttle Pharmactcls Hldgs In (SHPH) | 0.0 | $124k | NEW | 69k | 1.80 |
|
| Macrogenics (MGNX) | 0.0 | $121k | -6% | 75k | 1.61 |
|
| Pmv Pharmaceuticals (PMVP) | 0.0 | $111k | -8% | 89k | 1.25 |
|
| Hyperliquid Strategies (PURR) | 0.0 | $107k | NEW | 30k | 3.56 |
|
| Mangoceuticals Com New (MGRX) | 0.0 | $102k | NEW | 138k | 0.74 |
|
| Chemomab Therapeutics Sponsored Ads (CMMB) | 0.0 | $86k | -2% | 52k | 1.65 |
|
| Lyra Therapeutics Com New (LYRA) | 0.0 | $65k | 21k | 3.08 |
|
|
| Jasper Therapeutics Com New (JSPR) | 0.0 | $44k | -4% | 24k | 1.83 |
|
| Aethlon Med Com New (AEMD) | 0.0 | $40k | NEW | 14k | 2.77 |
|
| Rezolute Com New (RZLT) | 0.0 | $39k | NEW | 17k | 2.36 |
|
| Biomx Com New (PHGE) | 0.0 | $36k | NEW | 20k | 1.87 |
|
| Airsculpt Technologies (AIRS) | 0.0 | $33k | -8% | 16k | 1.98 |
|
| Theriva Biologics Com New (TOVX) | 0.0 | $24k | -6% | 112k | 0.21 |
|
| Synlogic Com New (SYBX) | 0.0 | $22k | -2% | 20k | 1.12 |
|
| Anebulo Pharmaceuticals (ANEB) | 0.0 | $18k | -88% | 18k | 1.01 |
|
| Autonomix Med Com New (AMIX) | 0.0 | $10k | -6% | 19k | 0.55 |
|
Past Filings by Ikarian Capital
SEC 13F filings are viewable for Ikarian Capital going back to 2019
- Ikarian Capital 2025 Q4 filed Feb. 18, 2026
- Ikarian Capital 2025 Q3 filed Nov. 14, 2025
- Ikarian Capital 2025 Q2 filed Aug. 14, 2025
- Ikarian Capital 2025 Q1 filed May 15, 2025
- Ikarian Capital 2024 Q4 filed Feb. 14, 2025
- Ikarian Capital 2024 Q3 filed Nov. 14, 2024
- Ikarian Capital 2024 Q2 filed Aug. 14, 2024
- Ikarian Capital 2024 Q1 restated filed May 17, 2024
- Ikarian Capital 2024 Q1 filed May 15, 2024
- Ikarian Capital 2023 Q4 filed Feb. 14, 2024
- Ikarian Capital 2023 Q3 filed Nov. 14, 2023
- Ikarian Capital 2023 Q2 filed Aug. 14, 2023
- Ikarian Capital 2023 Q1 filed May 15, 2023
- Ikarian Capital 2022 Q4 filed Feb. 14, 2023
- Ikarian Capital 2022 Q3 filed Nov. 14, 2022
- Ikarian Capital 2022 Q2 filed Aug. 12, 2022